Sign up for our eNewsletters
Get the latest news and updates

Industry News

Avid Bioservices, Inc
Exterior shot of Avid Bioservices' early-stage biologics facility
The 78,000-square-foot Costa Mesa facility is designed to support programs from cell line development through tech transfer into cGMP manufacturing.
Feb. 25, 2026
Akums
Exterior shot of India's Akums EU-GMP certified sites
The certification includes renewal for its oral solid dosage facility and first-time EU GMP approval for its oral liquid manufacturing site.
Feb. 25, 2026
AbbVie
3D rendering of exterior of new abbvie manufacturing building in North Chicago, Illinois
Construction is set to begin in spring 2026, with the two facilities in North Chicago expected to be fully operational in 2029 and supported by 300 new hires.
Feb. 24, 2026
Bora Pharmaceuticals
Aerial view of Bora's Mississauga, Ontario plant
The deal expands GSK’s access to Bora’s global network, including its oral solid dose site in Maple Grove, Minnesota.
Feb. 24, 2026

Learning Resources

gettyimages1337381197_1540x800
Sponsored
Learn how different temperature monitoring tools reveal what your pharmaceutical shipments experienced and how to choose the right one to protect your supply chain.
Feb. 12, 2026
dreamstime_xxl_249582173
dreamstime_xxl_249582173
Sponsored
Innovators are redefining bioreactor technology, cell and gene therapy manufacturing, pharmaceutical packaging, and small molecule APIs. Pharma Manufacturing’s 2025 Innovation...
Dec. 8, 2025
cover_gettyimages1320311776
cover_gettyimages1320311776
Sponsored
Faced with increasing quality, risk, and talent pressures, pharma manufacturers are embracing smart manufacturing and automation to overcome these challenges. Find out in this...
Nov. 20, 2025
dreamstime_m_45052120
dreamstime_m_45052120
Sponsored
Advancements in cleanroom technology are redefining pharmaceutical manufacturing with energy-efficient HVAC, sustainable materials, and intelligent airflow. However, much more...
Oct. 28, 2025

Podcast

Editors' (re)View

editreview
Industrializing the manufacturing of these complex therapies is critical to ensure scalability and commercial viability, says the Alliance for Regenerative Medicine.
Feb. 6, 2026
editreview
The annual J.P. Morgan Healthcare Conference in San Francisco brought together executives who are positive about this year’s prospects for the sector.
Jan. 16, 2026
editreview
Large pharmaceutical companies have promised to invest more than $370 billion over the next five years in the U.S., driven by Trump’s threat of pharma-specific tariffs.
Dec. 19, 2025
editreview
The deal is a win for Britain’s beleaguered pharma sector and comes after President Trump threatened to impose 100% tariffs on branded drugs imported to the U.S.
Dec. 5, 2025

Production

usflagcapitol
To counter the Chinese government’s investment, the U.S. must make a coordinated effort to grow biomanufacturing base, argues a bipartisan commission created by Congress.
Feb. 20, 2026
lillycorporatecentertmp190521988
The pharma giant has added to its inventory of orforglipron in anticipation of a favorable regulatory decision by the U.S. Food and Drug Administration.
Feb. 13, 2026
raleigh_skyline
Raleigh-Cary and Durham-Chapel Hill secured the first and third spots, respectively, as the nation’s most competitive markets for the production of therapeutic biologics.
Nov. 10, 2025
symphonxfinal
SymphonX, which runs all downstream unit operations in both fed-batch and continuous processes, will serve customers at Fujifilm’s Billingham manufacturing facility.
Nov. 6, 2025

Development

aidrugdiscovery_shutterstock
As artificial intelligence tools proliferate, the real challenge is not generating ideas but turning them into chemically feasible and manufacturable paths.
Feb. 17, 2026
shutterstock_radiopharmafinal
Manufacturers face growing pressure to align drug design, production strategy, logistics, and workforce planning to ensure reliable, at-scale delivery.
Jan. 6, 2026
hikmagroundbreaking
Report finds 40 states and Puerto Rico are offering sales and tax exemptions to lower costs for new biomanufacturing and research and development facilities.
Dec. 4, 2025
PlantForm
2171_plantform_104_high_res
Advances in glycosylation control, plant engineering, and rapid-expression systems are redefining what’s possible for plant-made drugs and vaccines.
Nov. 13, 2025

Information Technology

resilience2
Software platforms can seamlessly integrate with emerging technologies to unlock efficiencies, strengthen sustainability and enable proactive prevention of disruptions.
Sept. 10, 2025
2_1200xundefined
Sponsored
Pharmaceutical manufacturing operates in a high-stakes environment where regulatory compliance, product integrity, and operational uptime are non-negotiable. As the industry becomes...
March 5, 2025
shutterstock_1401286556
To prioritize data integrity in the lab, companies must implement good data practices throughout the R&D process
June 24, 2024
shutterstock_1970907203
Built-in ability to meet data integrity standards should be a central focus when selecting control systems and manufacturing execution systems for pharma manufacturing
May 2, 2024

Compliance

supremecourt
Despite the legal setback for President Trump’s country-specific tariffs, he retains the authority to impose Section 232 tariffs on pharmaceuticals imported to the U.S.
Feb. 20, 2026
wuxiapptecshanghai
A notice briefly posted online indicated the China-based company was indirectly affiliated with the People’s Liberation Army.
Feb. 16, 2026
fdawhiteoakbuilding
The agency will select new pharma manufacturing facilities for the pilot aimed at reducing inspection-related delays and creating a more predictable regulatory pathway.
Feb. 2, 2026
fda_shutterstock
While the FDA was hit with staffing and budget cuts this year, the agency managed to increase its inspection and enforcement activities.
Dec. 29, 2025

Quality & Risk

vaccinesafricafinal
Production is highly concentrated globally making lower- and middle-income regions vulnerable to supply shocks, regulatory bottlenecks, and slow pandemic response.
Feb. 9, 2026
us_brit_trumpfinal
Atradius and GlobalData see Britain as having a competitive advantage in attracting pharmaceutical production, thanks to tariff exemptions for drug exports to U.S.
Jan. 26, 2026
shutterstock_2026final
Biomanufacturing scaling and supply chain resilience are top priorities for biopharma companies as they look to mitigate risks and capitalize on growth opportunities.
Jan. 5, 2026
shipcontainersheroimage
The industry requires local resilience and flexibility in a complex global landscape, according to separate reports from consulting firms Deloitte and West Monroe.
Dec. 11, 2025